The Association of Psychological Stress with the Efficacy of Neoadjuvant Therapy in Breast Cancer

Recruiting now

Conditions studied: Breast Cancer

In brief

This study aims to explore the relationship between psychological stress and the therapeutic response in breast cancer patients who have received standard neoadjuvant chemotherapy.

Key facts

Study ID

NCT06690645

Run by

Shengjing Hospital

People needed

840

Starts

2024-11-15

Expected to finish

2026-12-31

Last updated by the study team

2024-11-15

Who can join

Age: 18 and older. Sex: female. Healthy volunteers: not accepted.

You may qualify if…

• 1.Age ≥ 18 years; 2.Histological and/or cytological diagnosis of breast cancer; 3.Treatment niave patients; 4.To receive standard neoadjuvant therapy; 5.Eastern Cooperative Oncology Group (ECOG) performance status of 0-1; 6.Presence of at least one measurable lesion according to the Response Evaluation Criteria in Advanced Solid Tumors version 1.1 (RECIST v1.1) ; 7.Informed and agreed to participate in the study;

You may not qualify if…

• 1. Breast cancer has not been confirmed through histological or cytological examinations.
• Other breast cancer conditions that do not receive neoadjuvant therapy. 3.Combined with other malignant tumors. 4.Concurrent acute or chronic psychiatric disorders, along with having received antidepressant or anti-anxiety therapy within the past month.
• Participants must not have engaged in any other clinical trials in the past month, unless those trials are observational or non-interventional in nature.

Where it is running

• Shengjing Hospital of China Medical University — Shenyang, Liaoning, China (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.